InVision Medical Technology
About InVision Medical Technology
InVision Medical Technology is a healthcare AI company dedicated to enhancing the precision and accuracy of cardiovascular imaging, primarily through the development of AI tools for echocardiography. Their solutions are designed to streamline the interpretation of heart ultrasounds, enabling physicians to quickly and accurately diagnose various heart conditions. The company’s AI models are integrated into clinical workflows to facilitate ease of use by clinicians and have been validated in clinical settings, with research published in prominent medical journals such as Nature, Nature Medicine, and JAMA Cardiology.
Specifically, InVision Medical Technology focuses on addressing critical unmet needs in cardiology, such as the early identification of cardiac amyloidosis, a rare and often underdiagnosed life-threatening disease. Their AI algorithm for cardiac amyloidosis has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA), recognizing its potential to accelerate diagnosis and improve patient outcomes. The company also develops AI for assessing heart function to aid in the early detection and treatment of heart failure. By leveraging AI, InVision aims to prevent misdiagnosis and underdiagnosis of rare diseases, democratizing access to expert knowledge and improving care for a broader patient population.
Focus Areas
Business Intelligence
| Key Investors | Y Combinator, Carnrite Ventures |
| Partnerships | Alexion, AstraZeneca Rare Disease, HeartLab |
| Technology | AI models integrated into clinical workflow, video AI models for echocardiography, advanced image post-processing analysis software, cloud-native (implied) |
| FDA Clearances | 2 cleared products (estimated) |
What Physicians Need to Know
InVision Medical Technology offers physicians several key advantages. Their FDA-cleared AI tools, like 'InVision Precision Cardiac Amyloid' and 'Precision LVEF,' enhance diagnostic accuracy and precision, especially for challenging and often missed conditions. The technology aids in the early detection of life-threatening diseases, potentially leading to earlier treatment and improved patient outcomes. Physicians can benefit from streamlined workflows, reduced interpretation time for ultrasounds, and a decrease in misdiagnosis or underdiagnosis. The availability of a new AMA Category III CPT code (0932T) for InVision Precision Cardiac Amyloid also supports reimbursement for these advanced diagnostic services. Furthermore, the rigorous validation through blinded, randomized clinical trials and publications in top medical journals provides strong evidence for the reliability of their AI algorithms.
InVision Medical Technology's solutions are designed for tight integration into existing clinical workflows. While specific details on their proprietary technology stack are not fully disclosed, their offerings are AI/ML-driven and process echocardiography DICOM images. They explicitly mention integration capabilities with major Electronic Health Record (EHR) systems such as Epic, Cerner, Allscripts, Athenahealth, Salesforce Health Cloud, Microsoft Teams, and Google Workspace, facilitating seamless adoption within diverse healthcare IT environments.
Reviews & Opinions
Videos
News, demos, and interviews about InVision Medical Technology.
Videos load interactively. If none appear, search YouTube for InVision Medical Technology →
Press & Coverage
Frequently Asked Questions
Comparisons
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]